📖 Top Journal Literature Interpretation | Bone Research ✨ 

There is an urgent unmet need for disease-modifying drugs for osteoarthritis 😭 This study reveals that inhibition of CDK8 achieves multi-dimensional protection across the whole joint! 

▪️🦴 Inhibit chondrocyte hypertrophy and promote cartilage matrix synthesis 

▪️⚡ Remodel chondrocyte mitochondrial metabolism and alleviate oxidative stress injury 

▪️🔥 Inhibit macrophages and reduce articular synovial inflammatory response 

▪️🦴 Regulate osteogenesis and osteoclastogenesis to ameliorate abnormal subchondral bone remodeling

✨ Key Highlights 💡 

👉 In vitro study: Short-term drug administration for only 48 h sustains the synthetic phenotype of chondrocytes stably, with therapeutic effects persisting after drug withdrawal. 

👉 In vivo study: STR/Ort spontaneous OA mice exhibit corrected gait, improved motor function and restored joint matrix. 👉 Human specimen validation: Aberrant nucleocytoplasmic translocation of CDK8‑MED12‑p‑STAT1 is observed in lesional cartilage from human OA patients, supporting the involvement of this pathway in human osteoarthritis pathogenesis.

⚠️ Limitations: No significant improvement was observed in the conventional OARSI cartilage damage score. Note: This target is more suitable for early intervention of osteoarthritis. Its capacity to reverse established large cartilage defects at advanced stages is limited, and conventional evaluation systems also have inherent constraints.

We provide full-process services for diverse material design, including highly innovative scheme design, fabrication, characterization, and in vitro & in vivo validation (cell and animal studies). Our team with postdoctoral backgrounds (multiple high-impact Q1 publications) addresses your challenging research demands, covering hydrogels, drug delivery, nanomaterials, polymers, liposomes, microneedle delivery systems, etc. We support project design, National Natural Science Foundation proposal preparation, and high-quality SCI manuscripts for journals such as AFM, AM and other Q1/Q2 journals. Enquiries are welcome👇 

17768014569 (Dr.Gao) 

17761925168 (Dr. Zhang) 

18013729810 (Dr. Yang)